HGS Patent Suits Against Genentech Head To Calif.

Law360, New York (July 19, 2011, 3:48 PM EDT) -- A Delaware federal judge on Monday moved three declaratory judgment and antitrust suits filed by Human Genome Sciences Inc. against Genentech Inc. to California, ruling a California judge's expertise with a patent-in-suit outweighs HGS' desire to keep the cases in Delaware.

In three suits filed between January and April, HGS brought declaratory judgment, antitrust, Lanham Act and state tort claims against Genentech over U.S. Patent Numbers 6,331,415 and 7,923,221, known as the Cabilly II and Cabilly III patents, respectively. HGS seeks a ruling that Genentech's patents...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.